Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-5,175
Closed -$353K 131
2025
Q1
$353K Sell
5,175
-56
-1% -$4.57K 0.29% 92
2024
Q4
$407K Sell
5,231
-651
-11% -$48.2K 0.33% 91
2024
Q3
$394K Buy
5,882
+1,492
+34% +$123K 0.32% 97
2024
Q2
$498K Buy
4,390
+425
+11% +$53.7K 0.43% 78
2024
Q1
$550K Buy
3,965
+426
+12% +$53.5K 0.48% 70
2023
Q4
$439K Buy
+3,539
New +$362K 0.42% 77

Other funds holding DXCM

DMC Group's DXCM Position: Q2 2025 in Review

DMC Group sold out of DexCom (DXCM) in Q2 2025, closing a stake of 5,175 shares — an estimated $353K sold.

DMC Group first reported a position in DXCM in Q4 2023 and held it in 6 quarters. The position peaked at $550K in Q1 2024. 939 funds tracked by Wall St. Rank hold DXCM as of Q2 2025.

  • DMC Group reported no remaining DexCom position as of Q2 2025 after selling out during the quarter.
  • DMC Group sold 5,175 DexCom shares in Q2 2025, an estimated $353K.
  • DMC Group first reported a position in DexCom in Q4 2023 and held it in 6 quarters.
  • DMC Group's DexCom position peaked at $550K in Q1 2024.
  • 939 funds tracked by Wall St. Rank held DexCom as of Q2 2025.

Based on DMC Group's 13F filing for Q2 2025, filed 23 Jul 2025.